PLUS1
150.40
0.27 (0.18%)
0.27 (0.18%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.03% | 150.13 | 149.15 | 150.65 | 150.65 | 150.09 | 19:59:36 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 42,016 | 5,716,550 | $ 150.03 | $ 857,656,912 | 6,648,873 | 124.56 - 154.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:32:04 | formt | 100 | $ 150.40 | USD |
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 395.12B | 2.63B | $ 15.30B | 5.63 | 26.70 | 2.63B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 20.87M | $ - | 253.11% | 02/24/20 | - | - |
Johnson and Johnson News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/14/2020 | 12:45 | Edgar (US Regulatory) | Form 13f Cover Page (13f-nt) |
| 2/13/2020 | 16:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/13/2020 | 16:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/13/2020 | 16:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/13/2020 | 16:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/13/2020 | 16:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/13/2020 | 16:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 153.34 | 153.58 | 149.15 | 151.34 | 4,978,607 | -3.21 | -2.09% |
| 1 Month | 148.44 | 154.50 | 146.00 | 150.14 | 6,876,335 | 1.69 | 1.14% |
| 3 Months | 136.65 | 154.50 | 135.15 | 145.43 | 6,342,788 | 13.48 | 9.86% |
| 6 Months | 132.53 | 154.50 | 124.56 | 136.56 | 7,024,793 | 17.60 | 13.28% |
| 1 Year | 134.30 | 154.50 | 124.56 | 136.64 | 6,878,864 | 15.83 | 11.79% |
| 3 Years | 115.44 | 154.50 | 115.32 | 133.89 | 6,409,870 | 34.69 | 30.05% |
| 5 Years | 99.39 | 154.50 | 81.79 | 122.68 | 6,474,991 | 50.74 | 51.05% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States. |
